1 / 71

PathoGenoMics

ERA-NET. PathoGenoMics. WP 2 Policy maker workshop of common understanding: Survey on the national programmes 7th April 2005, Bonn. 0. 12. 24. 36. 48. 60. Month. WP 10 DE Consortium management. WP 1 DE Status-quo of partner programmes. WP 2 DE Knowledge base for RTD strategies.

mahlah
Télécharger la présentation

PathoGenoMics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ERA-NET PathoGenoMics WP 2 Policy maker workshop of common understanding: Survey on the national programmes 7th April 2005, Bonn

  2. 0 12 24 36 48 60 Month WP 10 DE Consortium management WP 1 DE Status-quo of partner programmes WP 2 DE Knowledge base for RTD strategies WP 3 FR Strategic and analytic activities WP 4 FR Economic exploitation and job creation WP 5 FI Support for transnational consortium building WP 6 AT Human resources development and mobility WP 7 HU Management concept and tools WP 8 SP Implementing transnational activities Contracts 1st round Contracts 2nd round WP 9 IL Science and societyissues 9/04 9/05 9/06 9/07 9/08 9/09

  3. Deliverable No.: D 1.2 Information documents on the national programmes Delivery date: due Month 5 (in January 2005)Nature: ReportDissemination level: PPAim: Basis for development of best practices in programme implementation and management

  4. Questionnaire: Survey on the national RTD programmes • Part A: General Programme Description: A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics • Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Questionnaire: Survey on the national RTD landscape • Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders

  5. Part A: General Programme Description A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders A: General Programme Description

  6. Preceding Programmes: no Funding by: BMBWK 100% Funded by the Programme: - 2 Universities - 1 public Research Institute Total No. of funded projects: 2 No. of running projects: 2 Next update / redesign: in process A: General Programme Description AT Programme Name: GEN-AU – Austrian Genome Research Programme Programme Owner: BMBWK – Federal Ministry of Education, Science and Culture Programme Management Agency: Programme Office GEN-AU Part of the larger Programme: no Topic: genome research Objective: e.g. enhance national competitiveness, strengthen research capacities, inprove conditions for investments Start Year: 2001 End year: 2010 Further information: www.genomik.gen-au.at Total funding volume per year: 10.0 mio € (2004) (0.47 mio € Pathog.) Fixed Bugdet: yes

  7. Preceding Programmes: no Funding by: Research Academy 76% Private foundation 24% Funded by the Programme: - 7 Universities - 2 public Research Institutes- 1 Regulatory Body Total No. of funded projects: 15 No. of running projects: 15 ( 7 cons. of 2-4 Res. groups) Next update / redesign: none A: General Programme Description FI Programme Name: MICMAN – Microbes and Man Programme Owner: Academy of Finland and The Swedish Foundation for Strategic Research Programme Management Agency: National Public Health Institute Part of the larger Programme: no Topic: research on human-relevant microorganisms Objective: increase the knowledge of the interaction between host and microbe and apply this knowledge Start Year: 2003 End year: 2005 Further information: www.aka.fi/micman Total funding volume per year: 1.8 mio € Fixed Bugdet: yes

  8. A: General Programme Description FR Preceeding Programmes: - - Funding by: - - No data submitted Programme Name: Programme Owner: Programme Management Agency: Part of the larger Programme Topic: Objective: Start Year: End year: Further information: 8Fixed Budget: yes/no Funded by the Programme: - - - Total No. of funded projects: List of running projects: Next update / redesign:

  9. Preceding Programmes: no Funding by: BMBF (88.9%) involved companies (11.1%) Funded by the Programme: - 13 Universities - 2 Medical Centres - 4 public Research Institutes- 6 Companies Total No. of funded projects: 47 No. of running projects: 44 Next update / redesign: none A: General Programme Description DE Programme Name: Competence Center PathoGenoMik Programme Owner: BMBF – Federal Ministry of Education and Science Programme Management Agency: PTJ Part of the larger Programme: GenoMik (Genome Research in microorganisms) Topic: genome research on bacteria (GenoMik) Objective: use of the potential of microbial genomes for e.g. defeating human diseases Start Year: 2001 End year: 2006 Further information: www.genomik.uni-wuerzburg.de Total funding volume per year: 3.63 mio € (BMBF) (2003) Fixed Bugdet: yes

  10. Preceding Programmes: Funding by: Funded by the Programme: Total No. of funded projects: No. of running projects: Next update / redesign: A: General Programme Description HU No data submitted Programme Name: Programme Owner: Programme Management Agency: Part of the larger Programme: Topic: Objective: Start Year: nd year: Further information: Total funding volume per year: Fixed Bugdet:

  11. Preceding Programmes: no Funding by: CSO-MOH 100% Funded by the Programme: - Universities - Medical Centres - public Research Institutes Total No. of funded projects: 14 No. of running projects: 4 Next update / redesign: none A: General Programme Description IL Programme Name: NA Programme Owner: CSO-MOH – The Chief Scientist Office, Ministry of Health Programme Management Agency: NA Part of the larger Programme: no Topic: Objective: Start Year: continous End year: continuos Further information: www.health.gov.il Total funding volume per year: 0.16 mio € (2003) Fixed Bugdet: no

  12. A: General Programme Description LV • Preceeding Programmes: • - funct. Stability of microb. cultures • Genotoxicity by microorganisms • Mol. Studies on Borrellia burgd. Funding by: - LCS Programme Name: Molecular and epidemiological study of multiresistence and genetic variability of infections Programme Owner: Latvian Council of Science Programme Management Agency: NA Part of the larger Programme NA Topic: Objective: Start Year: 1998 End year: 2005 Further information: www.lzp.lv Total funding volume per year: 0,08 mio € Fixed Budget: yes Funded by the Programme: - 100% Universities Total No. of funded projects: 9 No. of running projects: 9 Next update / redesign: 2005

  13. A: General Programme Description PT Preceeding Programmes: - - Funding by: - - No data submitted Programme Name: Programme Owner: Programme Management Agency: Part of the larger Programme Topic: Objective: Start Year: End year: Further information: Total funding volume per year: ..mio € Fixed Budget: yes/no Funded by the Programme: - - - Total No. of funded projects: List of running projects: Next update / redesign:

  14. Preceeding Programmes: - No / yes A: General Programme Description SV • Funding by: • 100% MESC • 47% MESC • 47% Min. of Agric. For. + Food • 6% Min. of Health Programme Name: (10 different programmes) Programme Owner:Ministry of Higher Education, Science and Technology Programme Management Agency: programme managers in diverse institutions/Universities Part of the larger Programme: national programme for financing research programmes Topic: 1. target research programme 2. mol. Biology of microorganisms; pharmacolog. Chemistry; nutrition and ecology of gastroint. Tract; toxins and biomembranes etc. Start Year: 2001 / 2004 End year: 2006 / 2008 Further information: website in slovenian language Total funding volume per year: 0,496 mio € 2004 (6th them. Prior.) Fixed Budget: no • Funded by the Programme: • - 11 Universities • - 4 Medical Centers • 39 Public Res. Inst. • 1 priv. res. Inst. • 1 company Total No. of funded projects: 800 List of running projects: 450 Next update / redesign: 2006 / 2008

  15. Preceding Programmes: Yes National R&D plan 2000-03 Funding by: MEC 100% Funded by the Programme: - 19 Universities - 4 Medical Centres - 10 public Research Institutes Total No. of funded projects: 56 No. of running projects: 31 Next update / redesign: 2007 A: General Programme Description ES Programme Name: 1. Strategic Action on Genomics and Proteomics 2. Biotechnology Programme Owner: Ministry of Education and Science Programme Management Agency: NA Part of the larger Programme: National Plan of R&D Topic: different topics (e.g. genomics, proteomics etc.) Objective: functional analysis of genomes of human pathogens, characterisation of novel targets, pathogenicity mechanisms, host-pathogen-interactions, development of diagnostic tools Start Year: 2004 End year: 2007 Further information: web site in national language Total funding volume per year: 1.42 mio € (2004) Fixed Bugdet: no

  16. Next Programme update / redesign

  17. funded Institutions

  18. Project Analysis (projects related to PatoGenoMics)

  19. Part A: General Programme Description A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders

  20. Programme Design Process

  21. Analysis Initiation phase: Who influences the programme design? Scientific communities:AT, FI, IL, LV, SL, ES • Boards/ institutions: • Scientific Advisory Board: AT, DE, LV • Research Councils: AT,LV, SL Research councils AT, LV, SL influence Ministries AT – BMBWK DE – BMBF Ministries/funding authorities/Committees AT – BMBWK FI – Steering Programme Committee DE – BMBF IL – CSO-MOH LV – Program leader SL – Ministry of Science and Technology ES – MEC First idea Editing of the Call text Programme / Call Contents / text

  22. Part A: General Programme Description A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders A: General Programme Description

  23. Electronical Application/Submission System

  24. Rules for Submission System obligatory optional

  25. Application Support

  26. Application Process: 1 step or 2 step approach

  27. Elements of full proposals: • Name, coordinates, CV researcher(s) • scientific/technical description • Cost and time schedule • Management/organisation of networks • HR/ethical aspects • Relevance to programme • Relevance to industrial application Summary: Application / Submission Procedure Rules of procedure by: - ministry: AT, DE, IL, SL, ES - Academy/Council: FI, LV Approach: 1-step full proposals: DE, IL, LV, SL, ES Approach: 2-step Drafts + full proposals: AT, FI • Submission: • Electronically: FI, DE, IL, LV, ES • paper: AT, FI, DE, IL, LV, SL • Steps during Application • (draft proposal submission) • (draft proposal evaluation): AT, FI • full proposal submission • full proposal evaluation: DE, IL, LV, SL, ES • Support of applicants by: • Written manual: all except LV • Electr. Guidance: all • Helpdesk/contact person: all • Structure of draft: • Short descriptionof the project • Organisational andscientific concept

  28. Is the call permanently open or are there cut-off dates?

  29. Part A: General Programme Description A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders A: General Programme Description

  30. Evaluation Process - Evaluation by:

  31. Evaluation Process: Stakeholders present among the evaluators

  32. Evaluator characteristics • Evaluators • Evaluation by funding agency/authority: AT, FI, IL, LV, SL, ES • Evaluation by external advisory board: AT, FI, DE, SL, ES • Evaluation by peer review: AT, IL, SL From abroad: AT, FI, DE, LV, ES From Industry: AT, (IL), LV, ES Standing board: DE, LV, SL

  33. Are the Evaluators known to the Applicants?

  34. Can the final Evaluation result be overruled?

  35. 21 19 15 14 13 13 10 9 7 7 7 5 5 5 4 3 2 Analysis: Evaluation Criteria 25 20 15 score 10 5 0 Relevance to industrial Relevance to Ethical issues Societal value Internationality infrastructure Gender issues applicant / team potential of management International Scientific quality competitiveness Multidisciplinaritiy of proposal programme Training aspects standard of Project/resource Relevance to the written proposal Innovative potential, novelty, expertise, mobility of applicant / team Transfer of scientific record Evaluation criteria

  36. Analysis: most important Evaluation Criteria

  37. Analysis: most important evaluation criteria

  38. Is it possible to change the rules of the application/evaluation procedure? possible impossible

  39. Time from funding notification of funding authority/agency till project start Time from full proposal evaluation till funding notification of funding authority/agency Time from full proposal submissiontill full proposal evaluation Time from draft proposal evaluation till full proposal submission Time from draft proposal submission till draft proposal evaluation Time from call publication to draft (full) proposal submission How long does it take from publication of a call till start of a project? 14 12 10 8 months 6 4 2 0 Israel Spain Latvia Austria Finland Slovenia Slovenia Germany Partner

  40. 70% 63% 60% 50% 40% from drafts 40% 40% 30% 23% 16% from drafts 16% 20% 10% 0 Austria Finland Germany Israel Latvia Slovenia Slovenia Spain Spain project statistics: Average success rate of applications (drafts / full proposal versus funded projects)

  41. Part A: General Programme Description A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders A: General Programme Description

  42. Analysis: Funding possible impossible

  43. Analysis: cost models employed

  44. Part A: General Programme Description A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders A: General Programme Description

  45. Monitoring of ongoing projects

  46. Part A: General Programme Description A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders A: General Programme Description

  47. Relative economic Importance of Antiinfektives (2003)

  48. Most important anti-infektives selling companies (antiinfektives sales per year in mio €)

  49. Part A: General Programme Description A1: General Programme Information A2: History and Road Map of the Programme A3: Programme / Project statistics Part B: Programme management and implementation approaches B1: Programme Initiation B2: Application / Submission Procedure B3: Evaluation Process B4: Financial modalities, Legal and Contractual Framework B5: Project management, administrative procedures and Review of programme and projects Details on the national / regional Pathogenomics RTD landscape Research Content, Expertise Mapping, Economic Stakeholders A: General Programme Description

  50. Results of the national pathogenomics RTD landscape (expertise mapping etc.): www.pathogenomics-era.net(internal pages)

More Related